Production (Stage)
Protalix BioTherapeutics, Inc.
PLX
$1.58
$0.063.95%
AMEX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -0.25% | 27.08% | -39.13% | -7.13% | 8.81% |
Total Receivables | 37.70% | 54.67% | -78.32% | 169.38% | -34.67% |
Inventory | -8.18% | 23.51% | -16.99% | -7.28% | 17.33% |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1,345.45% | -89.52% | -29.67% | 83.87% | 529.46% |
Total Current Assets | 0.73% | 25.55% | -38.15% | 2.60% | 7.82% |
|
|||||
Total Current Assets | 0.73% | 25.55% | -38.15% | 2.60% | 7.82% |
Net Property, Plant & Equipment | -0.71% | -2.64% | -0.44% | -3.01% | -2.04% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 3.32% | -2.90% | -10.88% | 1.94% | 3.90% |
Total Assets | 0.65% | 19.26% | -32.75% | 1.91% | 6.38% |
|
|||||
Total Accounts Payable | -9.09% | 44.59% | -22.86% | 29.18% | -27.18% |
Total Accrued Expenses | 7.76% | 16.21% | -10.67% | 3.17% | -2.36% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -5.00% | -0.53% | -93.10% | -0.01% | 0.98% |
Total Finance Division Other Current Liabilities | -32.54% | -24.86% | -58.92% | 10.76% | 166.45% |
Total Other Current Liabilities | -32.54% | -24.86% | -58.92% | 10.76% | 166.45% |
Total Current Liabilities | -5.07% | 5.78% | -58.22% | 5.73% | 20.42% |
|
|||||
Total Current Liabilities | -5.07% | 5.78% | -58.22% | 5.73% | 20.42% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -5.34% | -3.59% | -2.48% | -4.82% | -2.64% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -1.43% | -23.42% | 3.55% | -0.98% | -0.28% |
Total Liabilities | -5.04% | 3.71% | -53.74% | 4.86% | 18.04% |
|
|||||
Common Stock & APIC | 1.33% | 1.03% | 0.15% | 0.24% | 0.14% |
Retained Earnings | -0.96% | 1.69% | 0.83% | -0.57% | -1.15% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 4.62% | 33.22% | 13.49% | -4.05% | -11.27% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 4.62% | 33.22% | 13.49% | -4.05% | -11.27% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 4.62% | 33.22% | 13.49% | -4.05% | -11.27% |
|